The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
this is an interesting paper the title is Statin stimulate atherosclerosis and heart failure pharmacological mechanisms is from expert reviews of clinical pharmacology in 2015 uh the authors are here the first author is Haruki okuyama
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
this is an interesting paper the title is statins stimulate atherosclerosis and heart failure pharmacological mechanisms is from expert reviews of clinical pharmacology in 2015. the authors are here the first author is Haruki okuyama